These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 9233617
21. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival. Chandrasekher G, Sailaja D. Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065 [Abstract] [Full Text] [Related]
22. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1. Jourdan M, De Vos J, Mechti N, Klein B. Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262 [Abstract] [Full Text] [Related]
23. Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide. Tamatani M, Ogawa S, Nuñez G, Tohyama M. Cell Death Differ; 1998 Oct; 5(10):911-9. PubMed ID: 10203697 [Abstract] [Full Text] [Related]
24. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. Kim K, Lee CK, Sayers TJ, Muegge K, Durum SK. J Immunol; 1998 Jun 15; 160(12):5735-41. PubMed ID: 9637482 [Abstract] [Full Text] [Related]
25. Bcl-xL overexpression restricts heat-induced apoptosis and influences hsp70, bcl-2, and Bax protein levels in FL5.12 cells. Robertson JD, Datta K, Kehrer JP. Biochem Biophys Res Commun; 1997 Dec 08; 241(1):164-8. PubMed ID: 9405251 [Abstract] [Full Text] [Related]
27. Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. Broome HE, Dargan CM, Krajewski S, Reed JC. J Immunol; 1995 Sep 01; 155(5):2311-7. PubMed ID: 7650367 [Abstract] [Full Text] [Related]
28. Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. Katoh O, Takahashi T, Oguri T, Kuramoto K, Mihara K, Kobayashi M, Hirata S, Watanabe H. Cancer Res; 1998 Dec 01; 58(23):5565-9. PubMed ID: 9850095 [Abstract] [Full Text] [Related]
29. Insulin-like growth factor II induces apoptosis in osteoblasts. Gronowicz GA, McCarthy MB, Zhang H, Zhang W. Bone; 2004 Sep 01; 35(3):621-8. PubMed ID: 15336597 [Abstract] [Full Text] [Related]
30. Costimulation with interleukin-4 and interleukin-10 induces mast cell apoptosis and cell-cycle arrest: the role of p53 and the mitochondrion. Bouton LA, Ramirez CD, Bailey DP, Yeatman CF, Yue J, Wright HV, Domen J, Rosato RR, Grant S, Fischer-Stenger K, Ryan JJ. Exp Hematol; 2004 Dec 01; 32(12):1137-45. PubMed ID: 15588938 [Abstract] [Full Text] [Related]
31. Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors. Giuliano M, Lauricella M, Vassallo E, Carabillò M, Vento R, Tesoriere G. Invest Ophthalmol Vis Sci; 1998 Jul 01; 39(8):1300-11. PubMed ID: 9660477 [Abstract] [Full Text] [Related]
32. Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells. Josefsen D, Myklebust JH, Lømo J, Sioud M, Blomhoff HK, Smeland EB. Stem Cells; 2000 Jul 01; 18(4):261-72. PubMed ID: 10924092 [Abstract] [Full Text] [Related]
33. Triggering of apoptosis by Puma is determined by the threshold set by prosurvival Bcl-2 family proteins. Callus BA, Moujallad DM, Silke J, Gerl R, Jabbour AM, Ekert PG, Vaux DL. J Mol Biol; 2008 Dec 12; 384(2):313-23. PubMed ID: 18835564 [Abstract] [Full Text] [Related]
34. Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1. DiGiuseppe JA, Kastan MB, Weng LJ, Gore SD. In Vivo; 1999 Dec 12; 13(1):1-6. PubMed ID: 10218124 [Abstract] [Full Text] [Related]
35. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Dumon S, Santos SC, Debierre-Grockiego F, Gouilleux-Gruart V, Cocault L, Boucheron C, Mollat P, Gisselbrecht S, Gouilleux F. Oncogene; 1999 Jul 22; 18(29):4191-9. PubMed ID: 10435632 [Abstract] [Full Text] [Related]
36. Apoptosis and Bcl-2 expression in cultured murine splenic T cells. Broome HE, Dargan CM, Bessent EF, Krajewski S, Reed JC. Immunology; 1995 Mar 22; 84(3):375-82. PubMed ID: 7751019 [Abstract] [Full Text] [Related]
37. Bcl-2 confers growth and survival advantage to interleukin 7-dependent early pre-B cells which become factor independent by a multistep process in culture. Borzillo GV, Endo K, Tsujimoto Y. Oncogene; 1992 May 22; 7(5):869-76. PubMed ID: 1373874 [Abstract] [Full Text] [Related]
38. Interleukin-3 and Bcl-2 cooperatively inhibit etoposide-induced apoptosis in a murine pre-B cell line. Ascaso R, Marvel J, Collins MK, López-Rivas A. Eur J Immunol; 1994 Mar 22; 24(3):537-41. PubMed ID: 7510234 [Abstract] [Full Text] [Related]
39. Growth factor starvation of bcl-2 overexpressing murine bone marrow cells induced refractoriness to IL-3 stimulation of proliferation. Marvel J, Perkins GR, Lopez Rivas A, Collins MK. Oncogene; 1994 Apr 22; 9(4):1117-22. PubMed ID: 8134114 [Abstract] [Full Text] [Related]
40. Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Kinoshita T, Yokota T, Arai K, Miyajima A. Oncogene; 1995 Jun 01; 10(11):2207-12. PubMed ID: 7784065 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]